Morenzo Abadi Perkasa Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Morenzo Abadi Perkasa Tbk. trades at Rp68 (market cap 149.22B, 1.66M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp258 (market cap 678.4B, 10.91M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 4.5× Morenzo Abadi Perkasa Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (10.91M versus 1.66M). Which is the better fit depends on your goals.
| ENZO | RSCH | |
|---|---|---|
Market Cap | 149.22B | 678.4B |
Volume | 1.66M | 10.91M |
Lot | 16.61K | 109.11K |
Turnover | 113.11M | 2.8B |
Average Price | 68.11 | 256.9 |
Value | 113.11M | 2.8B |
Indicative Equilibrium Price | 69 | 258 |
Indicative Equilibrium Volume | 66K | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.
Read more on ENZO →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →